Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom, Agena Face Lawsuit in India Over Terminated Exclusive Distribution Agreement

NEW YORK (GenomeWeb) – Indian firm AceProbe is suing Sequenom and Agena Bioscience over an alleged wrongful termination of a distribution agreement for the MassArray system.

The firm has asked the High Court of Delhi at New Delhi to declare the termination of the agreement illegal and issue an injunction against another firm acting as a distributor for the platform and reagents.

Sequenom sold its bioscience business, which included the MassArray mass spectrometry-based platform for measuring genetic target material and variations and related reagents, to Agena in June 2014 for $31.8 million.

In an August 2014 letter submitted to the court, Agena Asia Pacific Vice President Jeff Bryant told AceProbe Managing Director Puneet Chandna that Agena would end the relationship between the two firms. Bryant stated that there existed "no current signed distribution agreement in place between our two companies."

AceProbe submitted that on Jan. 1, 2014, Bryant, acting as Sequenom's director of business for the Asia-Pacific region, certified AceProbe as the exclusive distribution partner for all its products and services until Jan. 1, 2016. 

The court advised mediation between the parties, Chandna told GenomeWeb in an email, but those mediation efforts failed.

A Sequenom spokesperson told GenomeWeb in an email that the firm was "not actively involved in the lawsuit," and declined to comment further.

Agena did not respond to inquiries from GenomeWeb to comment on the case. 

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.